[go: up one dir, main page]

GB0005071D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB0005071D0
GB0005071D0 GB0005071A GB0005071A GB0005071D0 GB 0005071 D0 GB0005071 D0 GB 0005071D0 GB 0005071 A GB0005071 A GB 0005071A GB 0005071 A GB0005071 A GB 0005071A GB 0005071 D0 GB0005071 D0 GB 0005071D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0005071A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0212763A priority Critical patent/GB2371803A/en
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority to GB0005071A priority patent/GB0005071D0/en
Publication of GB0005071D0 publication Critical patent/GB0005071D0/en
Priority to AU12900/01A priority patent/AU1290001A/en
Priority to EP08015458A priority patent/EP2161286A1/en
Priority to AT00974682T priority patent/ATE411342T1/en
Priority to JP2001538975A priority patent/JP2003515323A/en
Priority to DE60040555T priority patent/DE60040555D1/en
Priority to CN00818416A priority patent/CN1423660A/en
Priority to PCT/GB2000/004317 priority patent/WO2001036486A2/en
Priority to CA002391925A priority patent/CA2391925A1/en
Priority to KR1020027006362A priority patent/KR20020049054A/en
Priority to EP00974682A priority patent/EP1242456B1/en
Priority to US10/016,686 priority patent/US7074909B2/en
Priority to US10/060,585 priority patent/US7276488B2/en
Priority to US10/334,235 priority patent/US7635687B2/en
Priority to US11/333,859 priority patent/US7514546B2/en
Priority to US11/482,552 priority patent/US20070161080A1/en
Priority to US11/834,649 priority patent/US20080175819A1/en
Priority to US12/121,621 priority patent/US20100040539A1/en
Priority to US12/845,380 priority patent/US20110052577A1/en
Ceased legal-status Critical Current

Links

GB0005071A 1997-06-04 2000-03-02 Antibodies Ceased GB0005071D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0212763A GB2371803A (en) 1999-11-18 1999-11-18 Antibodies
GB0005071A GB0005071D0 (en) 2000-03-02 2000-03-02 Antibodies
EP08015458A EP2161286A1 (en) 1999-11-18 2000-11-13 Antibodies
PCT/GB2000/004317 WO2001036486A2 (en) 1999-11-18 2000-11-13 Scfv antibodies against disease associated molecules
EP00974682A EP1242456B1 (en) 1999-11-18 2000-11-13 Scfv antibodies against disease associated molecules
AT00974682T ATE411342T1 (en) 1999-11-18 2000-11-13 SCFV ANTIBODIES AGAINST DISEASE-ASSOCIATED MOLECULES
JP2001538975A JP2003515323A (en) 1999-11-18 2000-11-13 Body
DE60040555T DE60040555D1 (en) 1999-11-18 2000-11-13 cules
CN00818416A CN1423660A (en) 1999-11-18 2000-11-13 Antibody
AU12900/01A AU1290001A (en) 1999-11-18 2000-11-13 Antibodies
CA002391925A CA2391925A1 (en) 1999-11-18 2000-11-13 Antibodies
KR1020027006362A KR20020049054A (en) 1999-11-18 2000-11-13 Antibodies
US10/016,686 US7074909B2 (en) 1999-11-18 2001-11-02 Antibodies
US10/060,585 US7276488B2 (en) 1997-06-04 2002-01-29 Vector system
US10/334,235 US7635687B2 (en) 1997-06-04 2002-12-30 Vector system
US11/333,859 US7514546B2 (en) 1999-11-18 2006-04-26 Antibodies
US11/482,552 US20070161080A1 (en) 1999-11-18 2006-07-07 Antibodies
US11/834,649 US20080175819A1 (en) 1997-06-04 2007-08-06 Vector system
US12/121,621 US20100040539A1 (en) 1999-11-18 2008-05-15 Vector System
US12/845,380 US20110052577A1 (en) 1999-11-18 2010-07-28 Antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0005071A GB0005071D0 (en) 2000-03-02 2000-03-02 Antibodies

Publications (1)

Publication Number Publication Date
GB0005071D0 true GB0005071D0 (en) 2000-04-26

Family

ID=9886843

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0005071A Ceased GB0005071D0 (en) 1997-06-04 2000-03-02 Antibodies

Country Status (1)

Country Link
GB (1) GB0005071D0 (en)

Similar Documents

Publication Publication Date Title
EP1432444A4 (en) Anti-a-beta antibodies
IL156030A0 (en) Humanized antibodies
AU1174702A (en) Humanized anti-lt-beta-r antibodies
AU3391801A (en) Pyridinylimidazoles
AU8274301A (en) Electro-powder
GB9911569D0 (en) Antibodies
AU2002365649A8 (en) Anti-dota antibody
AU6803901A (en) Bis-arylsulfones
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
GB2361622B (en) Carrying means
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
AU4686401A (en) Hypotensors
AU9187601A (en) Triazolo-epothilones
DE50100877D1 (en) Thermoverformbares verbundmaterial
DE50006446D1 (en) Otoplastik
AU8756801A (en) Thienopyrrolidinones
DE50003404D1 (en) Multi-master-bus-system
DE50013705D1 (en) Otoplastik
AU2001295042A1 (en) Anti-stilbene antibodies
GB0117601D0 (en) Pipe-chamfering means
GB0005071D0 (en) Antibodies
GB0003527D0 (en) Antibodies
GB0020568D0 (en) Novel antibody
GB0119553D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)